Clinical Protocol for Type 2 Diabetes: Glucose Control and Insulin Sensitivity

A functional protocol for managing type 2 diabetes using berberine, magnesium, and digestive enzymes. Supports insulin sensitivity and reduces glucose spikes.

Clinical Protocol for Type 2 Diabetes

This protocol supports glucose stability, improves insulin sensitivity, and strengthens metabolic health by combining targeted supplementation with functional lifestyle strategies.
Before starting any supplementation, we strongly encourage you to consult with your primary care physician.

Protocol Objectives

• Reduce insulin resistance
• Lower post-meal glucose spikes
• Improve carbohydrate digestion
• Support energy and cardiovascular health
• Stabilize nighttime fasting glucose levels

Phase 1: Morning (with breakfast)

Berberine Breakthrough – 1 capsule

Activates AMPK to improve insulin sensitivity and lower postprandial glucose, functioning similarly to natural metformin.

Magnesium Breakthrough – 2 capsules

Supports glucose regulation, muscle function, energy production, and reduces metabolic inflammation.

Phase 2: Lunch and Dinner (with meals)

MassZymes – 3 capsules per meal

High-potency digestive enzymes that improve breakdown of carbohydrates and proteins, reducing glucose spikes through improved digestion and absorption.

Phase 3: Night (before bed)

Berberine Breakthrough – 1 additional capsule

Provides nighttime glucose control to help stabilize basal levels during sleep.

Additional Recommendations

Diet

• Low in refined carbohydrates
• High in fiber (vegetables, legumes)
• Prioritize lean proteins and healthy fats

Lifestyle

• 30 minutes of daily aerobic exercise
• Adequate hydration
• Consistent meal schedule

Duration

• 90-day initial phase
• Maintenance phase afterward based on clinical response

Clinical Notes

• Start with half the dose for 3–5 days to assess tolerance
• Monitor for hypoglycemia if combined with antidiabetic medications
• Consider adding Microbiome Breakthrough if intestinal dysbiosis is present

Monitoring

• Fasting glucose

• Electrolytes

• Liver and kidney function

• Laboratory follow-up every 4–6 weeks